Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Actin-induced Endothelial Injury After Hematopoietic Stem Cell Transplant and Impact on Clinical Outcomes

ABSTRACT: Actin-induced Endothelial Injury After Hematopoietic Stem Cell Transplant and Impact on Clinical Outcomes

PROVIDER: PRJNA535501 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8956358.fastq.gz	Fastqsanger.gz
	SRR8956359.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Actin-induced Endothelial Injury After Hematopoietic Stem Cell Transplant and Impact on Clinical Outcomes

Project description:We report vitamin D binding protein levels in the serum alter macrophage function

2020-07-01 | GSE130323 | GEO

Myelofibrosis etiology and transplant outcomes

Project description:Myelofibrosis etiology and transplant outcomes

| PRJNA769154 | ENA

Myelofibrosis etiology and transplant outcomes

Project description:Myelofibrosis etiology and transplant outcomes

| PRJNA769155 | ENA

Transplant Outcomes in Aplastic Anemia (TOAA)

Project description:Transplant Outcomes in Aplastic Anemia (TOAA)

| PRJNA494901 | ENA

Transplant Outcomes in Aplastic Anemia (TOAA)

Project description:Transplant Outcomes in Aplastic Anemia (TOAA)

| PRJNA494902 | ENA

Gut microbiome and metabolome dynamics as predictors of clinical outcomes in hematopoietic stem cell transplantation

Project description:Hematopoietic stem cell transplantation (HSCT) induces significant alterations in the gut microbiome and metabolome, which influence transplant-related complications and surviv-al. This study longitudinally analyzed gut microbiota and metabolites at pre- (T1), peri- (T2), and post-transplant (T3) stages to identify key determinants of clinical outcomes. Lower microbiome diversity at T1 and T3 correlated with graft-versus-host disease (GVHD), progressive disease (PD), and reduced overall survival (OS). Short-chain fatty acids (SCFAs), particularly acetate, declined over time, with reductions at T2-T1 linked to GVHD, diarrhea, PD, and lower OS. Specific perspective metabolites (SPMs) such as elevated uric acid at T2 were associated with GVHD, while reduced 1-phenylethylamine correlated with diarrhea. Patients with enriched beneficial taxa (e.g., Lachnospiraceae, Ruminococcaceae) exhibited improved OS. These findings highlight the gut microbiome-metabolome axis as a predictive marker for HSCT outcomes. Identifying microbial and metabolic signatures may provide novel diagnostic and therapeutic targets for mitigating HSCT-related complications, enhancing patient prognosis.

2025-07-30 | MTBLS12365 | MetaboLights

NGS in hematopoietic cell transplant recipients

Project description:Transplant-associated thrombotic microangiopathy (TA-TMA) is a life-threatening complication of allogeneic hematopoietic cell transplantation (HCT). We hypothesized that pre-transplant genetic susceptibility is evident in adult TA-TMA patients at the level of TMA-associated variants and further investigated the association of genetic variants with clinical outcomes. We studied 30 patients with TA-TMA at a median of 73 (9-540) post-transplant days, donors of 18/30 patients and 30 control non-TMA HCT recipients, without significant differences in transplant characteristics. Genomic DNA from pre-transplant peripheral blood was analyzed by targeted next generation sequencing for complement regulatory genes and ADAMTS13. Donors presented significantly lower frequency of rare variants (p=0.049) and variants in exonic/splicing/UTR regions (p=0.025), compared to TA-TMA patients. Controls also showed a significantly lower frequency of rare variants in ADAMTS13 (p=0.001), CD46 (p=0.002), CFH (p=0.010) and CFI (p=0.031). Pathogenic variants were found in ADAMTS13, CFH, CFI and CFB, while homozygous pathogenic variants in ADAMTS13 and CFB were evident in only 4 TA-TMA patients (p=0.038). Patients refractory to conventional treatment (70%) were significantly (p=0.045) enriched for variants in exonic/splicing/UTR regions compared to responders. Nineteen of 30 patients (63%) succumbed to transplant-related mortality, which was also associated with significantly (p=0.012) increased frequency of variants in exonic/splicing/UTR regions. In conclusion, increased incidence of pathogenic, rare and variants in exonic/splicing/UTR regions of TA-TMA patients suggests genetic susceptibility not evident in controls or donors. Notably, variants in exonic/splicing/UTR regions were associated with poor response and survival. Therefore, pre-transplant genomic screening may be useful to intensify monitoring and early intervention in high-risk patients.

2019-04-18 | E-MTAB-7848 | biostudies-arrayexpress

Mechanisms of endothelial injury and transplant-associated thrombotic microangiopathy in tandem autologous hematopoietic stem cell transplant for neuroblastoma

Project description:Our data indicate that endothelial injury is increased in auto-stem cell transplant patients receiving the specific conditioning regimen carboplatin, etoposide and melphalan and is associated with clinical TA-TMA. Moreover, our data identify specific pathways that can be targeted to treat or prevent TA-TMA.

2023-09-11 | GSE227176 | GEO